Pliant Therapeutics, Inc. PLRX

Full chart Compare
Set alert

Price alert · PLRX

All alert types
0.82 USD -0.04 (-4.23%)

At closeNov 5, 2026, 4:00 PM EST

0.82 0.00 0.00%

After hours · Nov 5, 4:00 PM ET

0.7951 Day range 0.85
0.7951 52-week range 1.82
YTD
-33.13%
1 year
-50.26%

Revenue & Expenses

Other Income → Expenses: $24.08MExpenses → Selling, General & Admin: $57.93MExpenses → Research & Development: $127.80MExpenses → Interest Expense: $1.27MGross Profit → Expenses: $1.58MRevenue → Gross Profit: $1.58MNet Loss → Expenses: $161.34MOther Income$24.08MGross Profit$1.58MNet Loss$161.34MExpenses$186.99MSelling, General & Admin$57.93MResearch & Development$127.80MInterest Expense$1.27MRevenue$1.58M

Latest period ending Dec 31, 2025 · select a line to chart its full history

PLRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-156.37M-228.37M-184.15M-127.20M-97.53M
-149.34M-210.30M-161.34M-123.32M-97.26M
-2.43-3.47-2.75-2.94-2.71
PLRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
46.93M72.67M64.72M33.69M51.66M
225.23M396.95M512.15M350.61M221.22M
44.02M92.87M38.58M37.27M22.16M
29.11M60.19M11.37M15.81M7.19M
181.21M304.08M473.58M313.34M199.06M
PLRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-128.34M-155.50M-116.36M-94.63M-75.44M
134.29M140.34M-127.01M-150.20M73.70M
-31.70M23.12M274.40M226.85M2.53M
-219.00K-3.85M-921.00K-1.76M-1.95M
-25.74M7.95M31.03M-17.98M783.00K